Covid-19 vaccines for children

B J C Perera

doi:10.4038/sljch.v51i1.10006

Abstract

The Journal is the primary organ of Continuing Paediatric Medical Education in Sri Lanka. The journal also has a website. Free full text access is available for all readers.The Sri Lanka Journal of Child Health is now indexed in SciVerse Scopus (Source Record ID 19900193609), Index Medicus for South-East Asia Region (IMSEAR), CABI (Centre for Agriculture and Bioscience International Global Health Database), DOAJ and is available in Google, as well as Google Scholar.The policies of the journal are modelled on the Committee on Publication Ethics (COPE) Guidelines on Principles of Transparency and Best Practice in Scholarly Publishing. Sri Lanka Journal of Child Health is recognised by the International Committee of Medical Journal Editors (ICMJE) as a publication following the ICMJE Recommendations.

Highlights

In the last few months of evident uncertainty regarding the likely progression of SARS-CoV-2, there is considerable apprehension and intense anxiety amongst the general populace of our country
The antivaxxers blew up, out of all proportions, the quaint issue of vaccine-induced immune thrombotic thrombocytopenia (VITT) that has been reported after Covid-19 vaccinations
The most recent adverse effect of the Covid-19 vaccines that has been brought to light is the occurrence of myocarditis and to a lesser extent, pericarditis

Summary

Introduction

In the last few months of evident uncertainty regarding the likely progression of SARS-CoV-2, there is considerable apprehension and intense anxiety amongst the general populace of our country. Young adults and those under 60 years with coexisting other diseases were lined up. An article published in the New England Journal of Medicine in October 2021 estimated these clotting problems to occur in about 1 in 50,000 of those under 50 years of age who have received the Oxford-AstraZeneca vaccine[1].

Results

Conclusion